Advertisement
Screener

Carisma Therapeutics Inc. Patents: Active

Carisma Therapeutics Inc. Active Patents

8 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2021-09-16: Application 17477494; Invention Method of increasing tumor killing activity of macrophages or monocytes comprising chimeric antigen receptor; Applicant Carisma Therapeutics Inc.; Status Patented Case.
  • 2021-09-16: Application 17477491; Invention NOVEL CONSTRUCTS FOR CHIMERIC ANTIGEN RECEPTORS; Applicant Carisma Therapeutics Inc.; Status Patented Case.
  • 2021-09-16: Application 17477486; Invention NOVEL CONSTRUCTS FOR CHIMERIC ANTIGEN RECEPTORS; Applicant Carisma Therapeutics Inc.; Status Patented Case.
  • 2021-08-31: Application 17462654; Invention IL-6 ANTAGONIST FORMULATIONS AND USES THEREOF; Applicant SESEN BIO, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2021-09-1617477494Method of increasing tumor killing activity of macrophages or monocytes comprising chimeric antigen receptorCarisma Therapeutics Inc.Patented Case2023-08-2911739297US20220000918A1
Michael Klichinsky
Nicholas G. Minutolo
Nicholas R. Anderson
United States
United States
United States
STOICA, ELLY GERALD
2021-09-1617477491NOVEL CONSTRUCTS FOR CHIMERIC ANTIGEN RECEPTORSCarisma Therapeutics Inc.Patented Case2026-04-1412600796US20220000917A1
Michael Klichinsky
Nicholas G. Minutolo
Nicholas R. Anderson
United States
United States
United States
BURKHART, MICHAEL D
2021-09-1617477486NOVEL CONSTRUCTS FOR CHIMERIC ANTIGEN RECEPTORSCarisma Therapeutics Inc.Patented Case2022-04-2611312939US20220002675A1
Michael Klichinsky
Nicholas G. Minutolo
Nicholas R. Anderson
United States
United States
United States
BURKHART, MICHAEL D
2021-08-3117462654IL-6 ANTAGONIST FORMULATIONS AND USES THEREOFSESEN BIO, Inc.Patented Case2024-07-3012048746US20220241414A1
Grigorios Zarbis-Papastoitsis
Patricia Lowden
United States
United States
CARTER, SANDRA DILLAHUNT
2018-01-2615880575IL-6 ANTAGONISTS AND USES THEREOFELEVEN BIOTHERAPEUTICS, INC.Patented Case2022-10-0411459386US20180222975A1
Michael March Schmidt
Thomas M. Barnes
David V. Erbe
Eric Steven Furfine
Alison Tisdale
United States
United States
United States
United States
United States
MCCOLLUM, ANDREA K
2017-05-0515524727IL-6 ANTIBODIESSESEN BIO, INCPatented Case2021-10-1211142571US20190194312A1
Michael March Schmidt
Alison Tisdale
Eric Steven Furfine
Grigorios Zarbis-Papastoitsis
United States
United States
United States
United States
CARTER, SANDRA DILLAHUNT
2014-10-0714508068IL-6 ANTAGONISTS AND USES THEREOFELEVEN BIOTHERAPEUTICS, INC.Patented Case2018-04-249951130US20150125468A1
Michael March Schmidt
Thomas M. Barnes
David V. Erbe
Eric Steven Furfine
Alison Tisdale
United States
United States
United States
United States
United States
MCCOLLUM, ANDREA K
2014-08-1514460563CHIMERIC IL-1 RECEPTOR TYPE I AGONISTS AND ANTAGONISTSEleven Biotherapeutics, Inc.Patented Case2016-10-049458216US20150087818A1
Thomas M. Barnes
Jinzhao Hou
Bracken M. King
United States
United States
United States
MERTZ, PREMA MARIA